Ingles Markets Inc (IMKTA) shareholders
Close on Nov 17, 2026Market cap $1.61BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 1,218,101 | 8.40% | 13G (passive) amendment | Dec 31, 2023 |
| Brandes Investment Partners, LP | 1,160,533 | 8.00% | 13G (passive) amendment | Sep 30, 2025 |
| Dimensional Fund Advisors LP | 993,777 | 6.80% | 13G (passive) amendment | Mar 31, 2025 |
| River Road Asset Management, LLC | 976,424 | 6.70% | 13G (passive) amendment | Dec 31, 2024 |
| American Century Companies, Inc. Joint filing with American Century Investment Management, Inc. (5.30%), Stowers Institute for Medical Research (5.30%) and 1 more | 765,346 | 5.30% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IMKTA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,356,805 | 7.14% | $120.19M | +80,500 | 0.00% |
| Brandes Investment Partners, LP | 1,260,027 | 6.63% | $111.61M | +7,743 | 0.78% |
| Dimensional Fund Advisors LP | 935,060 | 4.92% | $82.83M | +18,882 | 0.02% |
| River Road Asset Management, LLC | 915,990 | 4.82% | $81.14M | −40,430 | 0.90% |
| American Century Companies Inc | 765,346 | 4.03% | $67.79M | +124,101 | 0.03% |
| Vanguard Capital Management LLC | 633,339 | 3.33% | $56.10M | +10,402 | 0.00% |
| Vanguard Portfolio Management LLC | 576,284 | 3.03% | $51.05M | +26,325 | 0.00% |
| Gamco Investors, Inc. Et Al | 548,931 | 2.89% | $48.62M | −24,960 | 0.44% |
| Geode Capital Management, LLC | 542,553 | 2.86% | $48.06M | +79,844 | 0.00% |
| Summer Road LLC | 433,678 | 2.28% | $38.42M | – | 23.86% |
| State Street Corp | 428,226 | 2.25% | $37.93M | +31,263 | 0.00% |
| Bragg Financial Advisors, Inc | 388,582 | 2.05% | $34.42M | +8,767 | 0.92% |
| Gabelli Funds LLC | 341,500 | 1.80% | $30.25M | −20,400 | 0.19% |
| Charles Schwab Investment Management Inc | 320,101 | 1.69% | $28.35M | −95,629 | 0.00% |
| Allianz Asset Management GmbH | 265,418 | 1.40% | $23.51M | +26,362 | 0.02% |
| Gate City Capital Management, LLC | 221,399 | 1.17% | $19.61M | – | 5.08% |
| Systematic Financial Management LP | 199,726 | 1.05% | $17.69M | −9,226 | 0.35% |
| Goldman Sachs Group Inc | 197,122 | 1.04% | $17.46M | −451 | 0.00% |
| Wallace Capital Management Inc. | 192,195 | 1.01% | $17.02M | −112 | 1.87% |
| Morgan Stanley | 171,527 | 0.90% | $15.19M | −23,492 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 237 | 14M | 74.9% | 32 / 86 | 70 / 22 | 1M | 1M |
| Q1 2026 | 232 | 14M | 74.9% | 53 / 74 | 63 / 19 | 3M | 1M |
| Q4 2025 | 203 | 13M | 70.3% | 29 / 64 | 75 / 23 | 1M | 1M |
| Q3 2025 | 198 | 13M | 71.0% | 26 / 81 | 58 / 20 | 1M | 1M |
| Q2 2025 | 195 | 13M | 68.2% | 23 / 78 | 66 / 29 | 1M | 1M |
| Q1 2025 | 203 | 13M | 68.8% | 24 / 64 | 79 / 21 | 1M | 1M |
| Q4 2024 | 201 | 13M | 67.6% | 31 / 74 | 74 / 35 | 1M | 1M |
| Q3 2024 | 208 | 13M | 65.8% | 26 / 78 | 69 / 18 | 2M | 1M |
| Q2 2024 | 202 | 12M | 64.7% | 31 / 94 | 49 / 25 | 1M | 1M |
| Q1 2024 | 198 | 12M | 65.6% | 24 / 74 | 68 / 30 | 1M | 1M |
| Q4 2023 | 205 | 12M | 63.7% | 28 / 69 | 74 / 20 | 1M | 1M |
| Q3 2023 | 199 | 12M | 62.9% | 19 / 75 | 71 / 24 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
242 funds held IMKTA in Q2 2026, 35% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of IMKTA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Avantis U.S. Small Cap Value ETF | 611,622 | 3.22% | $54.10M | 0.20% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 463,177 | 2.44% | $41.03M | 0.00% | Jun 30, 2026 |
| 1290 VT GAMCO Small Company Value Portfolio | 460,000 | 2.42% | $40.75M | 0.91% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 389,601 | 2.05% | $34.51M | 0.04% | Jun 30, 2026 |
| FPA Queens Road Small Cap Value Fund | 356,802 | 1.88% | $31.56M | 2.33% | May 31, 2026 |
| Vanguard Strategic Equity Fund | 253,845 | 1.34% | $22.49M | 0.18% | Jun 30, 2026 |
| Brandes Small Cap Value Fund | 248,669 | 1.31% | $22.03M | 3.47% | Jun 30, 2026 |
| AMG River Road Small Cap Value Fund | 245,705 | 1.29% | $22.12M | 2.21% | Jul 31, 2026 |
| U.S. Small Cap Value Portfolio | 224,258 | 1.18% | $20.19M | 0.10% | Jul 31, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 211,891 | 1.12% | $18.74M | 0.21% | May 31, 2026 |
| The Gabelli Small Cap Growth Fund | 180,000 | 0.95% | $15.94M | 0.83% | Jun 30, 2026 |
| PIMCO RAE US Small Fund | 171,462 | 0.90% | $15.19M | 0.40% | Jun 30, 2026 |
| Vanguard Consumer Staples Index Fund | 170,746 | 0.90% | $15.10M | 0.16% | May 31, 2026 |
| Royce Small-Cap Special Equity Fund | 168,000 | 0.88% | $14.88M | 3.11% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 163,198 | 0.86% | $14.69M | 0.04% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kevin Jerry Hefner | Director | – | – | Sep 16, 2026 |
| Rory A. Held | Director | 430,178 | 2.26% | May 27, 2026 |
| Dwight L. Jacobs | Director | 500 | 0.00% | May 21, 2026 |
| Larry Keith Collins | Director | 899 | 0.00% | Dec 1, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Dwight L. Jacobs Director | May 20, 2026 | Buy | +500 | $88.07 | $44.04K | 500 |
| Sharp Laura Ingle Director | Jun 27, 2024 | Sale | −5,901 | $68.02 | $401.39K | 0 |
| Sharp Laura Ingle Director | Jun 24, 2024 | Sale | −4,799 | $70.38 | $337.75K | 5,901 |
| Sharp Laura Ingle Director | Jun 11, 2024 | Sale | −4,000 | $70.38 | $281.52K | 10,700 |
| Sharp Laura Ingle Director | Jun 10, 2024 | Sale | −6,000 | $70.25 | $421.50K | 14,700 |
| Sharp Laura Ingle Director | Mar 28, 2024 | Sale | −4,000 | $76.25 | $305.00K | 20,700 |
| Sharp Laura Ingle Director | Mar 25, 2024 | Sale | −2,000 | $76.00 | $152.00K | 24,700 |
| Sharp Laura Ingle Director | Mar 21, 2024 | Sale | −2,000 | $76.00 | $152.00K | 26,700 |
| Sharp Laura Ingle Director | Mar 20, 2024 | Sale | −2,000 | $75.00 | $150.00K | 28,700 |
| Sharp Laura Ingle Director | Mar 4, 2024 | Sale | −4,000 | $77.47 | $309.88K | 30,700 |
| Sharp Laura Ingle Director | Feb 29, 2024 | Sale | −3,000 | $77.16 | $231.48K | 34,700 |
| Sharp Laura Ingle Director | Feb 27, 2024 | Sale | −5,000 | $77.00 | $385.00K | 37,700 |
| Sharp Laura Ingle Director | Sep 29, 2023 | Sale | −2,000 | $75.05 | $150.10K | 42,700 |
| Sharp Laura Ingle Director | Sep 28, 2023 | Sale | −2,000 | $75.50 | $151.00K | 44,700 |
| Sharp Laura Ingle Director | Sep 27, 2023 | Sale | −2,298 | $75.50 | $173.50K | 46,700 |
| Sharp Laura Ingle Director | Sep 26, 2023 | Sale | −702 | $75.13 | $52.74K | 48,998 |
| Sharp Laura Ingle Director | Sep 25, 2023 | Sale | −3,683 | $76.14 | $280.42K | 49,700 |
| Sharp Laura Ingle Director | Sep 22, 2023 | Sale | −317 | $75.50 | $23.93K | 53,383 |
| Sharp Laura Ingle Director | Sep 21, 2023 | Sale | −2,000 | $75.26 | $150.52K | 53,700 |
| Sharp Laura Ingle Director | Sep 20, 2023 | Sale | −2,000 | $75.50 | $151.00K | 55,700 |
| Sharp Laura Ingle Director | Sep 15, 2023 | Sale | −2,000 | $77.50 | $155.00K | 57,700 |
| Sharp Laura Ingle Director | Sep 14, 2023 | Sale | −4,000 | $76.55 | $306.20K | 59,700 |
| Sharp Laura Ingle Director | Sep 12, 2023 | Sale | −4,000 | $75.75 | $303.00K | 63,700 |
| Sharp Laura Ingle Director | Sep 11, 2023 | Sale | −8,000 | $75.01 | $600.08K | 67,700 |
| Sharp Laura Ingle Director | Sep 8, 2023 | Sale | −2,000 | $75.00 | $150.00K | 75,700 |
| Sharp Laura Ingle Director | Aug 11, 2023 | Sale | −1,000 | $83.00 | $83.00K | 77,700 |
| Sharp Laura Ingle Director | Aug 11, 2023 | Sale | −1,000 | $83.00 | $83.00K | 0 |
| Sharp Laura Ingle Director | Aug 10, 2023 | Sale | −1,000 | $82.71 | $82.71K | 78,700 |
| Sharp Laura Ingle Director | Aug 10, 2023 | Sale | −1,000 | $82.71 | $82.71K | 1,000 |
| Sharp Laura Ingle Director | Jun 27, 2023 | Conversion | +77,700 | – | – | 79,700 |
| Sharp Laura Ingle Director | Mar 9, 2023 | Sale | −500 | $94.60 | $47.30K | 2,000 |
| Sharp Laura Ingle Director | Mar 8, 2023 | Sale | −500 | $92.89 | $46.45K | 2,500 |
| Sharp Laura Ingle Director | Mar 3, 2023 | Sale | −500 | $92.08 | $46.04K | 3,000 |
| Sharp Laura Ingle Director | Dec 9, 2022 | Sale | −2,000 | $100.71 | $201.42K | 3,500 |
| Sharp Laura Ingle Director | Jun 24, 2022 | Sale | −500 | $88.10 | $44.05K | 5,500 |
| Sharp Laura Ingle Director | Jun 15, 2022 | Sale | −500 | $89.25 | $44.63K | 6,000 |
| Sharp Laura Ingle Director | Mar 16, 2022 | Sale | −500 | $92.00 | $46.00K | 6,500 |
| Sharp Laura Ingle Director | Mar 8, 2022 | Sale | −500 | $89.40 | $44.70K | 7,000 |
| James W. Lanning CEO, President and COO, Director | Nov 26, 2021 | Conversion | +9,936 | – | – | 9,936 |
| James W. Lanning CEO, President and COO, Director | Nov 26, 2021 | Sale | −9,936 | $77.48 | $769.84K | 0 |
| Sharp Laura Ingle Director | Mar 26, 2021 | Sale | −7,500 | $64.50 | $483.75K | 7,500 |
| Sharp Laura Ingle Director | Mar 25, 2021 | Sale | −10,000 | $63.44 | $634.40K | 15,000 |
| Sharp Laura Ingle Director | Mar 23, 2021 | Sale | −2,000 | $64.33 | $128.66K | 25,000 |
| Sharp Laura Ingle Director | Mar 2, 2021 | Sale | −1,500 | $55.20 | $82.80K | 27,000 |
| Sharp Laura Ingle Director | Feb 9, 2021 | Sale | −1,500 | $52.03 | $78.05K | 28,500 |
| John R. Lowden Director | Dec 15, 2020 | Buy | +600 | $42.05 | $25.23K | 600 |
| Sharp Laura Ingle Director | Dec 9, 2020 | Sale | −2,500 | $42.27 | $105.68K | 30,000 |
| Sharp Laura Ingle Director | Dec 19, 2019 | Sale | −2,500 | $47.44 | $118.60K | 32,500 |
| Sharp Laura Ingle Director | Sep 9, 2019 | Sale | −5,000 | $41.04 | $205.20K | 5,000 |
| Sharp Laura Ingle Director | Sep 6, 2019 | Sale | −3,712 | $40.23 | $149.33K | 10,000 |
| Sharp Laura Ingle Director | Sep 5, 2019 | Sale | −1,288 | $40.05 | $51.58K | 13,712 |
| Sharp Laura Ingle Director | Jun 28, 2019 | Sale | −5,000 | $31.06 | $155.30K | 15,000 |
| Sharp Laura Ingle Director | Jun 17, 2019 | Sale | −5,000 | $32.01 | $160.05K | 20,000 |
| Sharp Laura Ingle Director | Mar 28, 2019 | Sale | −2,500 | $27.39 | $68.48K | 25,000 |
| Sharp Laura Ingle Director | Mar 11, 2019 | Other | +30,000 | – | – | 35,000 |
| Sharp Laura Ingle Director | Aug 23, 2018 | Sale | −2,500 | $36.00 | $90.00K | 27,500 |
| Ernest E. Ferguson Director | Aug 21, 2018 | Buy | +250 | $33.61 | $8.40K | 250 |
| Sharp Laura Ingle Director | Nov 3, 2017 | Option exercise | +30,000 | – | – | 30,000 |
| Sharp Laura Ingle Director | Sep 26, 2017 | Sale | −2,500 | $25.18 | $62.95K | 0 |
| Sharp Laura Ingle Director | Sep 22, 2017 | Sale | −2,500 | $24.76 | $61.90K | 2,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ingles Markets's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sharp Laura Ingle Director | Jun 27, 2024 | 5,901 | $401.41K | Jun 27, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Jun 24, 2024 | 4,799 | $337.75M | Jun 24, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Jun 11, 2024 | 4,000 | $281.52K | Jun 11, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Jun 10, 2024 | 6,000 | $421.49K | Jun 10, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Mar 28, 2024 | 4,000 | $305.00K | Mar 28, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Officer | Mar 25, 2024 | 2,000 | $152.00K | Mar 25, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Officer | Mar 21, 2024 | 2,000 | $152.00K | Mar 21, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Officer | Mar 20, 2024 | 2,000 | $150.00K | Mar 20, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Officer | Mar 4, 2024 | 4,000 | $309.86K | Mar 4, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Officer | Feb 29, 2024 | 3,000 | $231.48K | Feb 29, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Officer | Feb 27, 2024 | 5,000 | $385.01K | Feb 27, 2024 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Sep 29, 2023 | 2,000 | $150.10K | Sep 29, 2023 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Sep 28, 2023 | 2,000 | $151.00K | Sep 28, 2023 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Sep 27, 2023 | 2,298 | $173.50K | Sep 27, 2023 | Private Acquisition from Issuer/Affiliate |
| Sharp Laura Ingle Director | Sep 26, 2023 | 702 | $52.74K | Sep 26, 2023 | Private Acquisition from Issuer/Affiliate |
Congress trades
2 trades in Ingles Markets reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Virginia Foxx NC05 · joint account | Sold | Sep 30, 2022 | $15K–50K | Oct 12, 2022 |
| Virginia Foxx NC05 · joint account | Bought | Aug 30, 2022 | $50K–100K | Sep 8, 2022 |
See a number that looks wrong?